Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 1.1% in the morning session after it reported third-quarter 2025 results where revenue beat Wall Street's expectations.

$NEO insiders have traded $NEO stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales. Here’s a ...